Liquid-chromatographic determination of guanidino compounds in plasma and erythrocyte of normal persons and uremic patients. 1981

T Kikuchi, and Y Orita, and A Ando, and H Mikami, and M Fujii, and A Okada, and H Abe

We describe a method for determination of guanidino compounds in plasma and erythrocytes. The compounds are separated by liquid chromatography, the concentrations in the effluent being estimated fluorometrically (Trans. Am. Soc. Artif. Intern. Organs 24: 61, 1978). Guanidinoacetic acid, guanidinosuccinic acid, guanidinobutyric acid, guanidine, methylguanidine, taurocyamine, and arginine can be detected and quantitated in both plasma and erythrocytes from healthy individuals. The method was also applied to patients in chronic renal failure. Guanidinosuccinic acid, creatinine, guanidine, and methylguanidine are substantially increased in the plasma and erythrocytes of the uremic patient. Guanidino compounds can be effectively extracted from plasma with 0.5 volume of 300 g/L trichloroacetic acid, from erythrocytes with five volumes of 120 g/L trichloroacetic acid.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D006146 Guanidines A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013050 Spectrometry, Fluorescence Measurement of the intensity and quality of fluorescence. Fluorescence Spectrophotometry,Fluorescence Spectroscopy,Spectrofluorometry,Fluorescence Spectrometry,Spectrophotometry, Fluorescence,Spectroscopy, Fluorescence
D014511 Uremia A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms. Uremias

Related Publications

T Kikuchi, and Y Orita, and A Ando, and H Mikami, and M Fujii, and A Okada, and H Abe
May 2012, Journal of chromatographic science,
T Kikuchi, and Y Orita, and A Ando, and H Mikami, and M Fujii, and A Okada, and H Abe
July 1985, Clinical chemistry,
T Kikuchi, and Y Orita, and A Ando, and H Mikami, and M Fujii, and A Okada, and H Abe
August 1985, Journal of chromatography,
T Kikuchi, and Y Orita, and A Ando, and H Mikami, and M Fujii, and A Okada, and H Abe
September 1999, Renal failure,
T Kikuchi, and Y Orita, and A Ando, and H Mikami, and M Fujii, and A Okada, and H Abe
February 2001, Kidney international. Supplement,
T Kikuchi, and Y Orita, and A Ando, and H Mikami, and M Fujii, and A Okada, and H Abe
March 1984, Antimicrobial agents and chemotherapy,
T Kikuchi, and Y Orita, and A Ando, and H Mikami, and M Fujii, and A Okada, and H Abe
February 2001, Kidney international. Supplement,
T Kikuchi, and Y Orita, and A Ando, and H Mikami, and M Fujii, and A Okada, and H Abe
January 2009, Seminars in dialysis,
T Kikuchi, and Y Orita, and A Ando, and H Mikami, and M Fujii, and A Okada, and H Abe
November 2004, Journal of separation science,
T Kikuchi, and Y Orita, and A Ando, and H Mikami, and M Fujii, and A Okada, and H Abe
September 1981, Analytical chemistry,
Copied contents to your clipboard!